Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers [PDF]
Tropical Medicine and Infectious Disease, 2019 Background: Major intercontinental outbreaks of invasive meningococcal disease associated with the Hajj occurred in 1987, 2000, and 2001. Mandatory meningococcal vaccination for all pilgrims against serogroups A and C and, subsequently, A, C, W, and Y ...
Al-Mamoon Badahdah +10 more
doaj +3 more sources
Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review. [PDF]
Infect Dis Ther, 2022 While invasive meningococcal disease (IMD) is uncommon, it can result in serious sequelae and even death. In 2018 in the United States, the incidence of IMD per 100,000 people was 0.03 among adolescents 11−15 years of age, 0.10 among persons 16−23 years ...
Marshall GS +3 more
europepmc +2 more sources
Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations. [PDF]
Hum Vaccin Immunother, 2020 Invasive meningococcal disease (IMD) caused by the bacteria Neisseria meningitidis is rare but potentially fatal. For healthy adolescents, the US Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination with MenACWY and ...
Huang L +5 more
europepmc +2 more sources
The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae. [PDF]
Clin Infect Dis, 2019 Background Neisseria gonorrhoeae and Neisseria meningitidis are closely-related bacteria that cause a significant global burden of disease. Control of gonorrhoea is becoming increasingly difficult, due to widespread antibiotic resistance.
Semchenko EA, Tan A, Borrow R, Seib KL.
europepmc +2 more sources
Adoption of Serogroup B Meningococcal Vaccine Recommendations. [PDF]
Pediatrics, 2018 We examined how primary care physicians are adopting the MenB vaccine after it received a category B recommendation by the ACIP in 2015. BrightcoveDefaultPlayer10.1542/6138648371001PEDS-VA_2018-0344 Video Abstract BACKGROUND AND OBJECTIVES: In 2015, the ...
Kempe A +9 more
europepmc +2 more sources
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
npj Vaccines, 2021 Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical manifestations, but the bacteria share up to 80–90% genome sequence identity.
Yara Ruiz García +9 more
doaj +2 more sources
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia [PDF]
New England Journal of Medicine, 2020 BACKGROUND: The meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain.
Martin C. J. Maiden +17 more
openaire +6 more sources
Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage [PDF]
Frontiers in Cellular and Infection Microbiology, 2023 Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children.
Emilija Sereikaitė +10 more
doaj +2 more sources
Analysis of novel meningococcal vaccine formulations [PDF]
Human Vaccines & Immunotherapeutics, 2017 The protective effect of meningococcal vaccines targeting disease causing serogroups exemplified by the introduction of MenAfriVac™ in Africa, is well established and documented in large population-based studies.
Susu M. Zughaier
doaj +2 more sources
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
New England Journal of Medicine, 2020 BACKGROUND In September 2015, the United Kingdom introduced the multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded national immunization program at a reduced two-dose priming schedule for infants, with a 12-month ...
Shamez N Ladhani +2 more
exaly +2 more sources